Next Article in Journal
Method Development and Validation of Almotriptan in Human Plasma by HPLC Tandem Mass Spectrometry: Application to Pharmacokinetic Study
Previous Article in Journal
Development of a Stability-Indicating RP-UPLC Method for Rapid Determination of Metaxalone and its Degradation Products in Solid Oral Dosage Form
 
 
Search for Articles:
Title / Keyword
Author / Affiliation / Email
Journal
Article Type
 
 
Advanced Search
 
Section
Special Issue
Volume
Issue
Number
Page
 
Journals
Sci. Pharm.
Volume 81
Issue 4
10.3797/scipharm.1208-18err
scipharm-logo
Submit to this Journal Review for this Journal Propose a Special Issue
► Article Menu

Article Menu

share Share announcement Help format_quote Cite question_answer Discuss in SciProfiles thumb_up
...
Endorse textsms
...
Comment
Scientia Pharmaceutica is published by MDPI from Volume 84 Issue 3 (2016). Previous articles were published by another publisher in Open Access under a CC-BY (or CC-BY-NC-ND) licence, and they are hosted by MDPI on mdpi.com as a courtesy and upon agreement with Austrian Pharmaceutical Society (Österreichische Pharmazeutische Gesellschaft, ÖPhG).
first_page
settings
Order Article Reprints
Font Type:
Arial Georgia Verdana
Font Size:
Aa Aa Aa
Line Spacing:
Column Width:
Background:
Article

Erratum to "Intranasal Delivery of Chitosan Nanoparticles for Migraine Therapy" [Sci Pharm. 2013; 81: 843–854]

by
Neha GULATI
1,*,
Upendra NAGAICH
1 and
Shubhini A. SARAF
2
1
Department of Pharmaceutics, School of Pharmacy, Bharat Institute of Technology, Meerut, UP, India
2
School of Biosciences and Biotechnology, Babasaheb Bhimrao Ambedkar University, Lucknow, India
*
Author to whom correspondence should be addressed.
Sci. Pharm. 2013, 81(4), 1167-1172; https://doi.org/10.3797/scipharm.1208-18err
Submission received: 4 October 2013 / Accepted: 6 October 2013 / Published: 6 October 2013
Versions Notes

Abstract

This is an erratum to the article 'Intranasal Delivery of Chitosan Nanoparticles for Migraine Therapy' [Sci Pharm. 2013; 81: 843–854]. Figures 1–3 are added.
Keywords: Erratum; Sci Pharm. 2013; 81: 843–854 Erratum; Sci Pharm. 2013; 81: 843–854

Share and Cite

MDPI and ACS Style

GULATI, N.; NAGAICH, U.; SARAF, S.A. Erratum to "Intranasal Delivery of Chitosan Nanoparticles for Migraine Therapy" [Sci Pharm. 2013; 81: 843–854]. Sci. Pharm. 2013, 81, 1167-1172. https://doi.org/10.3797/scipharm.1208-18err

AMA Style

GULATI N, NAGAICH U, SARAF SA. Erratum to "Intranasal Delivery of Chitosan Nanoparticles for Migraine Therapy" [Sci Pharm. 2013; 81: 843–854]. Scientia Pharmaceutica. 2013; 81(4):1167-1172. https://doi.org/10.3797/scipharm.1208-18err

Chicago/Turabian Style

GULATI, Neha, Upendra NAGAICH, and Shubhini A. SARAF. 2013. "Erratum to "Intranasal Delivery of Chitosan Nanoparticles for Migraine Therapy" [Sci Pharm. 2013; 81: 843–854]" Scientia Pharmaceutica 81, no. 4: 1167-1172. https://doi.org/10.3797/scipharm.1208-18err

APA Style

GULATI, N., NAGAICH, U., & SARAF, S. A. (2013). Erratum to "Intranasal Delivery of Chitosan Nanoparticles for Migraine Therapy" [Sci Pharm. 2013; 81: 843–854]. Scientia Pharmaceutica, 81(4), 1167-1172. https://doi.org/10.3797/scipharm.1208-18err

Article Metrics

Back to TopTop